Source:http://linkedlifedata.com/resource/pubmed/id/20105429
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2010-3-9
|
pubmed:abstractText |
Cancer preventive reagent trans-resveratrol is intracellularly biotransformed to different metabolites. However, it is still unclear whether trans-resveratrol exerts its biological effects directly or through its metabolite(s). This issue was addressed here by identifying the metabolic pattern and the bioactive form of resveratrol in a resveratrol-sensitive human medulloblastoma cell line, UW228-3. The cell lysates and condition media of UW228-3 cells with or without 100 microM resveratrol treatment were analyzed by HPLC and LC/MS which revealed (1) that resveratrol was chemically unstable and the spontaneous generation of cis-resveratrol reduced resveratrol's anti-medulloblastoma efficacy and (2) that resveratrol monosulfate was the major metabolite of the cells. To identify the bioactive form of resveratrol, a mixture-containing approximately half fraction of resveratrol monosulfate was prepared by incubating trans-resveratrol with freshly prepared rat brain lysates. Medulloblastoma cells treated by 100 microM of this mixture showed attenuated cell crisis. The overall levels of the three brain-associated sulfotransferases (SULT1A1, 1C2 and 4A1) were low in medulloblastoma cells in vivo and in vitro in comparison with that in human noncancerous and rat normal cerebella; resveratrol could more or less up-regulate the production of these enzymes in UW228-3 cells but their overall level was still lower than that in normal cerebellum tissue. Our study thus demonstrated for the first time that trans-resveratrol is the bioactive form in medulloblastoma cells in which the expression of brain-associated SULTs was down-regulated, resulting in the increased intracellular bioavailability and anti-medulloblastoma efficacy of trans-resveratrol.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1873-2968
|
pubmed:author |
pubmed-author:ChenXiao-YanXY,
pubmed-author:FuYuan-ShanYS,
pubmed-author:KongQing-YouQY,
pubmed-author:LeeL JLJ,
pubmed-author:LiHongH,
pubmed-author:MaJing-XinJX,
pubmed-author:ShuXiao-HongXH,
pubmed-author:SunYuanY,
pubmed-author:SunZhengZ,
pubmed-author:WangJian-MinJM,
pubmed-author:WangQianQ,
pubmed-author:WuMo-LiML
|
pubmed:copyrightInfo |
2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1516-25
|
pubmed:meshHeading |
pubmed-meshheading:20105429-Adolescent,
pubmed-meshheading:20105429-Animals,
pubmed-meshheading:20105429-Antineoplastic Agents,
pubmed-meshheading:20105429-Biotransformation,
pubmed-meshheading:20105429-Blotting, Western,
pubmed-meshheading:20105429-Cell Line, Tumor,
pubmed-meshheading:20105429-Cerebellar Neoplasms,
pubmed-meshheading:20105429-Child,
pubmed-meshheading:20105429-Chromatography, High Pressure Liquid,
pubmed-meshheading:20105429-Humans,
pubmed-meshheading:20105429-Medulloblastoma,
pubmed-meshheading:20105429-Rats,
pubmed-meshheading:20105429-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20105429-Stilbenes,
pubmed-meshheading:20105429-Sulfotransferases,
pubmed-meshheading:20105429-Young Adult
|
pubmed:year |
2010
|
pubmed:articleTitle |
Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.
|
pubmed:affiliation |
Department of Cell Biology, Dalian Medical University, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|